Tous les services de P.I.
Toutes les politiques
Toutes les activités de coopération
Toutes les sources d'information
Tout sur la P.I.
34, chemin des Colombettes
CH-1211 Genève 20, Suisse
Venez nous rendre visite |
Au sein de l'OMPI
Interrogation > Anglais > 2019
Contracting Parties or Signatories to Treaties Administered by WIPO
Members of the WIPO Assemblies and other Bodies and Committees. Members of the International Union for the Protection of New Varieties of Plants (UPOV). Status on April 15, 2019
Année de publication: 2019
Japan FIT/IP Global
Activities in Africa and LDCs – 2019
The History of Japan FIT/IP for Africa and Least Developed Countries (LDCs)
Intellectual Property Basics: A Q&A for Students
Compiled by the China National Intellectual Property Administration (CNIPA) with the support of the WIPO China Funds-in-Trust, this book gives students a basic yet comprehensive understanding of IP. Using a question-and-answer format, it covers the general rules of the IP system as well as the essentials of patents, copyright, trademarks and other forms of IP, such as industrial designs, geographical indications and traditional knowledge.
Report of the Director General to the 2019 WIPO Assemblies
This report is a presentation of the work accomplished by the Organization during the year that has passed since the last meeting of the WIPO Assemblies.
WIPO Re:Search: Advancing Product Development for Neglected Infectious Diseases through Global Public-Private Partnerships
WIPO Re:Search Consortium unites public and private market forces to address neglected tropical diseases (NTDs), malaria, and tuberculosis (TB) through sharing of intellectual property across sectors and geographies. To date, WIPO Re:Search has catalyzed over 150 R&D collaborations and managed capacity-building fellowships for scientists across sub-Saharan Africa and other low- and middle-income regions. This publication highlights seven exciting collaborations that are advancing solutions to help over one billion people who suffer from NTDs, malaria, and TB.
WIPO Re:Search Partnership Stories 2016-2019: Driving R&D for Neglected Infectious Diseases Through Global Cross-Sector Collaborations
WIPO Re:Search is a global public-private consortium that accelerates drug, vaccine, and diagnostic research and development (R&D) to address unmet medical needs for neglected infectious diseases and drive progress toward the United Nations Sustainable Development Goals. Established in 2011, WIPO Re:Search catalyzes royalty-free sharing of intellectual property—including compounds, data, clinical samples, technology, and expertise—among Consortium Members in targeted, mutually beneficial R&D collaborations. This publication contain stories of collaborations established through WIPO Re:Search from 2016 to 2019.
WIPO Collection of Leading Judgments on Intellectual Property Rights
People's Republic of China (2011–2018)
This casebook of judgments by the Supreme People's Court of the People's Republic of China is the first volume in the WIPO Collection of Leading Judgments on Intellectual Property Rights. The WIPO Collection gives the global intellectual property community access to landmark judgments from some of the most dynamic litigation jurisdictions of the world, through a succession of volumes that illustrate intellectual property adjudication approaches and trends by jurisdiction or by theme.
A Guide to the Main WIPO Services
The World Intellectual Property Organization offers a wide range of global IP services. They provide a highly efficient, fast and cost-effective means of helping innovators and creators - both corporate and individual - protect their inventions, trademarks and designs in multiple countries, and also resolve their IP disputes, including those involving domain names. This brochure offers a brief overview of these global services.
Guidelines to using evidence from research to support policymaking
This Guide elaborates on the best practices in conducting empirical studies in the intellectual property (IP) field. In so doing, it seeks to improve the credibility of studies, enhance transparency about what conclusions can and cannot be drawn from such studies, and encourage responsible use of studies by IP stakeholders.
Urgent Innovation – Policies and Practices for Effective Response to Public Health Crises
Public health crises require urgent innovation, not only in research and development (R&D) but also in the delivery of therapies and diagnostics. What constitutes “urgency” and “innovation” in these contexts? How are priorities and targets determined? Who is best placed to deliver results? This edition of the Global Challenges in Focus series explores themes discussed at a recent Global Challenges Seminar on the policies and practices that facilitate effective responses to global health crises.